The effectiveness of TRPA1 or TRPV1 in these models may not mimic/reflect the future findings in human AD that is characterized as a more complexed and heterogenous disease, in which the multiple cytokines may potentiates several TRP channels. This evidence concerns the gene TRPV1 and Alzheimer disease.